Grifols (GRFS) Finished Goods (2016 - 2025)

Grifols (GRFS) reported Finished Goods of $1.0 billion for Q4 2025, down 11.33% on a YoY basis from $1.1 billion in Q4 2024, and down 11.33% quarter-over-quarter from $1.1 billion in Q4 2024.

Grifols (GRFS) Finished Goods (2016 - 2025) Analysis & Trends

Grifols has reported Finished Goods for 10 years, with the latest figure at $1.0 billion in Q4 2025.

  • For the quarter ending Q4 2025, Finished Goods fell 11.33% year-over-year to $1.0 billion; the trailing twelve-month figure through Dec 2025 stood at $1.0 billion (down 11.33% YoY), and the FY2025 full-year result was $1.0 billion, down 11.33% from the prior year.
  • Finished Goods for Q4 2025 stood at $1.0 billion, down from $1.1 billion in the prior quarter.
  • The five-year high for Finished Goods was $1.1 billion in Q4 2024, with the low at $679.5 million in Q4 2022.
  • Historically, Finished Goods has averaged $950.8 million across 5 years, with a median of $1.0 billion in 2025.
  • Annual changes were most pronounced in 2022 — Finished Goods declined 20.09% — and 2023, when it soared 60.26%.
  • Grifols' Finished Goods stood at $850.3 million in 2021, then slipped by 20.09% to $679.5 million in 2022, then soared by 60.26% to $1.1 billion in 2023, then increased by 3.92% to $1.1 billion in 2024, then dropped by 11.33% to $1.0 billion in 2025.
  • The last three Finished Goods figures came in at $1.0 billion (Q4 2025), $1.1 billion (Q4 2024), and $1.1 billion (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Grifols 6.05 Bn 5.09 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.00 Bn
Dec 31, 2024 1.13 Bn
Dec 31, 2023 1.09 Bn
Dec 31, 2022 679.51 Mn
Dec 31, 2021 850.34 Mn
Dec 31, 2020 708.36 Mn
Dec 31, 2019 570.63 Mn
Dec 31, 2018 500.67 Mn
Dec 31, 2017 561.99 Mn
Dec 31, 2016 506.45 Mn